Markku Tammi Selected Research

Obesity

11/2016	High extent of O-GlcNAcylation in breast cancer cells correlates with the levels of HAS enzymes, accumulation of hyaluronan, and poor outcome.
1/2014	Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Markku Tammi Research Topics

Disease

20	Neoplasms (Cancer) 01/2021 - 02/2002
12	Breast Neoplasms (Breast Cancer) 02/2020 - 04/2004
6	Carcinoma (Carcinomatosis) 01/2020 - 02/2002
3	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2002
3	Carcinogenesis 01/2019 - 12/2007
3	Inflammation (Inflammations) 01/2019 - 10/2014
3	Melanoma (Melanoma, Malignant) 01/2016 - 12/2012
3	Ovarian Epithelial Carcinoma 03/2004 - 11/2002
2	Obesity 11/2016 - 01/2014
2	Wounds and Injuries (Trauma) 06/2013 - 05/2005
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Lymphatic Metastasis 01/2020
1	Reinjuries 01/2019
1	Septic Shock (Toxic Shock Syndrome) 01/2014
1	Sepsis (Septicemia) 01/2014
1	Fatty Liver 10/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2013
1	Radiation Injuries (Radiation Sickness) 06/2013
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2010
1	Lichen Sclerosus et Atrophicus (Lichen Sclerosus) 01/2010
1	Hyperplasia 05/2005
1	Hypertrophy 10/2004
1	Ovarian Neoplasms (Ovarian Cancer) 11/2003
1	Cysts 11/2002
1	Thyroid Neoplasms (Thyroid Cancer) 02/2002

Drug/Important Bio-Agent (IBA)

29	Hyaluronic Acid (Hyaluronan)IBA 01/2021 - 02/2002
5	EnzymesIBA 01/2018 - 12/2007
4	Hyaluronan SynthasesIBA 11/2016 - 05/2005
3	GlycosaminoglycansIBA 01/2020 - 12/2007
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2016
3	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 09/2015 - 11/2002
2	SugarsIBA 01/2018 - 01/2016
2	Uridine Diphosphate (UDP)IBA 01/2018 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 11/2016 - 01/2014
2	Phosphotransferases (Kinase)IBA 09/2015 - 12/2012
2	OligosaccharidesIBA 09/2015 - 11/2002
2	Messenger RNA (mRNA)IBA 10/2014 - 05/2005
2	Indicators and Reagents (Reagents)IBA 01/2014 - 11/2003
2	Trastuzumab (Herceptin)FDA Link 08/2012 - 11/2007
2	Versicans (Versican)IBA 04/2004 - 11/2003
2	Polysaccharides (Glycans)IBA 11/2002 - 02/2002
1	Uridine Diphosphate Glucuronic Acid (UDP Glucuronic Acid)IBA 01/2018
1	Uridine Diphosphate SugarsIBA 01/2018
1	AcetylglucosamineIBA 01/2018
1	CytokinesIBA 05/2015
1	Estrogen ReceptorsIBA 01/2014
1	Blood Proteins (Serum Proteins)IBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2013
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2013
1	lardIBA 10/2013
1	Linseed Oil (Flaxseed Oil)IBA 10/2013
1	LipidsIBA 10/2013
1	AcidsIBA 10/2013
1	Hormones (Hormone)IBA 02/2013
1	Conditioned Culture MediaIBA 12/2012
1	CollagenIBA 12/2012
1	Matrix Metalloproteinases (MMPs)IBA 12/2012
1	Small Interfering RNA (siRNA)IBA 12/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2007
1	AntioxidantsIBA 12/2007
1	Tyrosine (L-Tyrosine)FDA Link 12/2007
1	Estrogens (Estrogen)FDA Link 12/2007
1	Progesterone Receptors (Progesterone Receptor)IBA 12/2007
1	3-nitrotyrosineIBA 12/2007
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2007
1	Epidermal Growth Factor (EGF)IBA 10/2004
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 04/2004
1	TenascinIBA 04/2004
1	Proteoglycans (Proteoglycan)IBA 11/2003
1	Protein Isoforms (Isoforms)IBA 02/2002
1	ParaffinIBA 02/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 10/2015
1	Therapeutics 01/2014
1	Lasers (Laser) 03/2004